2024
Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people?
Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.Peer-Reviewed Original ResearchBehavioral Risk Factor Surveillance SurveyCancer clinical trial enrollmentClinical trial enrollmentTrial enrollmentRisk Factor Surveillance SurveySGM peopleNon-SGM individualsClinical trial participationCancer disparitiesSurveillance SurveyReport participationGender minority peopleTrial participantsSGM statusSGM individualsPartnership statusLogistic regressionCisgender peopleData collection methodsEnrollmentOncological treatmentOddsMinority peopleParticipantsSGM
2022
Gender- and Sexual Orientation- Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology.
Alpert A, Scout N, Schabath M, Adams S, Obedin-Maliver J, Safer J. Gender- and Sexual Orientation- Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology. American Society Of Clinical Oncology Educational Book 2022, 42: 1-17. PMID: 35658501, DOI: 10.1200/edbk_350175.Peer-Reviewed Original ResearchConceptsTransgender identityTransgender peopleGender minoritiesImpact of stigmaGender identitySexual orientationSGM peopleStructural discriminationSGM patientsSGMPromote inclusionGenderSystem changesU.S. populationOncology settingPeopleStigmaIdentityGenderqueerQueerTransgenderAgenderComprehensive data collectionCancer disparitiesInequality